[
    [
        {
            "time": "2019-09-09",
            "original_text": "【民生医药|周报】外包行业09/09：创新药申报高景气，关注CMO产能转移趋势",
            "features": {
                "keywords": [
                    "创新药",
                    "申报",
                    "高景气",
                    "CMO",
                    "产能转移"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "外包行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【民生医药|周报】外包行业09/09：创新药申报高景气，关注CMO产能转移趋势",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-06-30",
            "original_text": "富途证券：回看生物科技2019H1：是“大”时代？还是“新”时代？",
            "features": {
                "keywords": [
                    "生物科技",
                    "回顾",
                    "大时代",
                    "新时代"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "富途证券：回看生物科技2019H1：是“大”时代？还是“新”时代？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 5,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        },
        {
            "time": "2019-08-15",
            "original_text": "【民生医药|公司深度】药明康德：医药外包龙头从β到α的路径展望",
            "features": {
                "keywords": [
                    "药明康德",
                    "医药外包",
                    "龙头",
                    "β到α"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "外包行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【民生医药|公司深度】药明康德：医药外包龙头从β到α的路径展望",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-07-20",
            "original_text": "医药外包深度：【民生医药|行业深度】中国市场红利逻辑下，医药外包公司弹性不一样",
            "features": {
                "keywords": [
                    "医药外包",
                    "中国市场",
                    "红利逻辑",
                    "弹性"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "外包行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药外包深度：【民生医药|行业深度】中国市场红利逻辑下，医药外包公司弹性不一样",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-09-10",
            "original_text": "【民生医药|公司深度】康龙化成：能力边界突破、规模性逐步体现的全球化CRO公司",
            "features": {
                "keywords": [
                    "康龙化成",
                    "能力边界",
                    "规模性",
                    "全球化CRO"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "外包行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【民生医药|公司深度】康龙化成：能力边界突破、规模性逐步体现的全球化CRO公司",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]